PPARD and melanoma: Moreover, disruption of PPARβ/δ signaling pathway by either antagonist or gene knock-down led to melanoma progression [22], whereas activation or overexpression of PPARβ/δ inhibited cell cycle progression in the G2/M phase of melanoma cells in ectopic xenografts [40].